Evaluation of Budesonide/Formoterol SPIROMAX® Versus SYMBICORT® TURBOHALER®
- Study Title
- Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAXֲ® Inhalation Powder Versus SYMBICORTֲ® TURBOHALERֲ®
- Teva Identifier
- BFS-AS-306 | 2013-000081-11
- ClinicalTrials.gov Identifier
- NCT01803555
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Budesonide/Formoterol SPIROMAXֲ® | Drug: SYMBICORTֲ® TURBOHALERֲ®
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child, Adult, Older Adult
- Age Range
- 12 Years and older
- Trial Duration
- 06/01/2013 - 07/01/2014
- Phase
- Phase 3
